Surgical management of pediatric renin-mediated hypertension secondary to renal artery occlusive disease and abdominal aortic coarctation.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
12 2020
Historique:
received: 17 10 2019
accepted: 15 02 2020
pubmed: 11 4 2020
medline: 16 3 2021
entrez: 11 4 2020
Statut: ppublish

Résumé

Renovascular hypertension (RVH) associated with renal artery and abdominal aortic narrowings is the third most common cause of pediatric hypertension. Untreated children may experience major cardiopulmonary complications, stroke, renal failure, and death. The impetus of this study was to describe the increasingly complex surgical practice for such patients with an emphasis on anatomic phenotype and contemporary outcomes after surgical management as a means of identifying those factors responsible for persistent or recurrent hypertension necessitating reoperation. A retrospective analysis was performed of consecutive pediatric patients with RVH undergoing open surgical procedures at the University of Michigan from 1991 to 2017. Anatomic phenotype and patient risk factors were analyzed to predict outcomes of blood pressure control and the need for secondary operations using ordered and binomial logistic multinomial regression models, respectively. There were 169 children (76 girls, 93 boys) who underwent primary index operations at a median age of 8.3 years; 31 children (18%) had neurofibromatosis type 1, 76 (45%) had abdominal aortic coarctations, and 28 (17%) had a single functioning kidney. Before treatment at the University of Michigan, 51 children experienced failed previous open operations (15) or endovascular interventions (36) for RVH at other institutions. Primary surgical interventions (342) included main renal artery (136) and segmental renal artery (10) aortic reimplantation, renal artery bypass (55), segmental renal artery embolization (10), renal artery patch angioplasty (8), resection with reanastomosis (4), and partial or total nephrectomy (25). Non-renal artery procedures included patch aortoplasty (32), aortoaortic bypass (32), and splanchnic arterial revascularization (30). Nine patients required reoperation in the early postoperative period. During a mean follow-up of 49 months, secondary interventions were required in 35 children (21%), including both open surgical (37) and endovascular (14) interventions. Remedial intervention to preserve primary renal artery patency or a nephrectomy if such was impossible was required in 22 children (13%). The remaining secondary procedures were performed to treat previously untreated disease that became clinically evident during follow-up. Age at operation and abdominal aortic coarctation were independent predictors for reoperation. The overall experience revealed hypertension to be cured in 74 children (44%), improved in 78 (46%), and unchanged in 17 (10%). Children undergoing remedial operations were less likely (33%) to be cured of hypertension. There was no perioperative death or renal insufficiency requiring dialysis after either primary or secondary interventions. Contemporary surgical treatment of pediatric RVH provides a sustainable overall benefit to 90% of children. Interventions in the very young (<3 years) and concurrent abdominal aortic coarctation increase the likelihood of reoperation. Patients undergoing remedial surgery after earlier operative failures are less likely to be cured of hypertension. Judicious postoperative surveillance is imperative in children surgically treated for RVH.

Sections du résumé

BACKGROUND
Renovascular hypertension (RVH) associated with renal artery and abdominal aortic narrowings is the third most common cause of pediatric hypertension. Untreated children may experience major cardiopulmonary complications, stroke, renal failure, and death. The impetus of this study was to describe the increasingly complex surgical practice for such patients with an emphasis on anatomic phenotype and contemporary outcomes after surgical management as a means of identifying those factors responsible for persistent or recurrent hypertension necessitating reoperation.
METHODS
A retrospective analysis was performed of consecutive pediatric patients with RVH undergoing open surgical procedures at the University of Michigan from 1991 to 2017. Anatomic phenotype and patient risk factors were analyzed to predict outcomes of blood pressure control and the need for secondary operations using ordered and binomial logistic multinomial regression models, respectively.
RESULTS
There were 169 children (76 girls, 93 boys) who underwent primary index operations at a median age of 8.3 years; 31 children (18%) had neurofibromatosis type 1, 76 (45%) had abdominal aortic coarctations, and 28 (17%) had a single functioning kidney. Before treatment at the University of Michigan, 51 children experienced failed previous open operations (15) or endovascular interventions (36) for RVH at other institutions. Primary surgical interventions (342) included main renal artery (136) and segmental renal artery (10) aortic reimplantation, renal artery bypass (55), segmental renal artery embolization (10), renal artery patch angioplasty (8), resection with reanastomosis (4), and partial or total nephrectomy (25). Non-renal artery procedures included patch aortoplasty (32), aortoaortic bypass (32), and splanchnic arterial revascularization (30). Nine patients required reoperation in the early postoperative period. During a mean follow-up of 49 months, secondary interventions were required in 35 children (21%), including both open surgical (37) and endovascular (14) interventions. Remedial intervention to preserve primary renal artery patency or a nephrectomy if such was impossible was required in 22 children (13%). The remaining secondary procedures were performed to treat previously untreated disease that became clinically evident during follow-up. Age at operation and abdominal aortic coarctation were independent predictors for reoperation. The overall experience revealed hypertension to be cured in 74 children (44%), improved in 78 (46%), and unchanged in 17 (10%). Children undergoing remedial operations were less likely (33%) to be cured of hypertension. There was no perioperative death or renal insufficiency requiring dialysis after either primary or secondary interventions.
CONCLUSIONS
Contemporary surgical treatment of pediatric RVH provides a sustainable overall benefit to 90% of children. Interventions in the very young (<3 years) and concurrent abdominal aortic coarctation increase the likelihood of reoperation. Patients undergoing remedial surgery after earlier operative failures are less likely to be cured of hypertension. Judicious postoperative surveillance is imperative in children surgically treated for RVH.

Identifiants

pubmed: 32276020
pii: S0741-5214(20)30473-0
doi: 10.1016/j.jvs.2020.02.045
pmc: PMC7541589
mid: NIHMS1582758
pii:
doi:

Substances chimiques

Antihypertensive Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2035-2046.e1

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL139672
Pays : United States

Informations de copyright

Copyright © 2020 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Références

Arch Surg. 1981 May;116(5):669-76
pubmed: 6786260
AJR Am J Roentgenol. 1996 Jan;166(1):157-62
pubmed: 8571868
J Pediatr Surg. 2018 Sep;53(9):1825-1831
pubmed: 29397961
Pediatrics. 1997 Jan;99(1):44-9
pubmed: 8989336
Pediatr Nephrol. 2016 May;31(5):809-17
pubmed: 26628283
J Vasc Surg. 1995 Feb;21(2):212-26; discussion 226-7
pubmed: 7853595
J Pediatr Surg. 1998 Jan;33(1):106-11
pubmed: 9473112
J Vasc Surg. 2018 Jun;67(6):1664-1672
pubmed: 29342430
Nephrol Dial Transplant. 2010 Mar;25(3):807-13
pubmed: 19846390
Diagn Interv Radiol. 2014 May-Jun;20(3):285-92
pubmed: 24675165
J Vasc Interv Radiol. 2010 Nov;21(11):1672-80
pubmed: 20884235
Congenit Heart Dis. 2018 May;13(3):349-356
pubmed: 29635838
Arch Surg. 1973 Nov;107(5):692-8
pubmed: 4200678
J Vasc Surg. 2008 Nov;48(5):1073-82
pubmed: 18692352
Pediatr Radiol. 1998 Jan;28(1):59-63
pubmed: 9426277
J Pediatr Surg. 2017 Mar;52(3):395-399
pubmed: 27634559
Kidney Blood Press Res. 2017;42(3):617-627
pubmed: 28950261
Pediatrics. 2017 Sep;140(3):
pubmed: 28827377
Pediatrics. 2006 Jul;118(1):268-75
pubmed: 16818574
Pediatr Nephrol. 2006 Jun;21(6):820-7
pubmed: 16703375
J Urol. 1990 Sep;144(3):717-20
pubmed: 2388335
Curr Hypertens Rep. 2014 Apr;16(4):422
pubmed: 24522941
J Vasc Surg. 2006 Dec;44(6):1219-28; discussion 1228-9
pubmed: 17055693
Am J Hypertens. 2018 May 7;31(6):687-695
pubmed: 29373648
Lancet. 2008 Apr 26;371(9622):1453-63
pubmed: 18440428

Auteurs

Dawn M Coleman (DM)

Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, Mich. Electronic address: dawnbarn@med.umich.edu.

Jonathan L Eliason (JL)

Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, Mich.

Robert Beaulieu (R)

Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, Mich.

Tatum Jackson (T)

Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, Mich.

Monita Karmakar (M)

Department of Surgery, University of Michigan, Ann Arbor, Mich.

David B Kershaw (DB)

Division of Pediatric Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor, Mich.

Zubin J Modi (ZJ)

Division of Pediatric Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor, Mich; Susan B. Meister Child Evaluation and Research Center, University of Michigan, Ann Arbor, Mich.

Santhi K Ganesh (SK)

Division of Cardiovascular Medicine, Department of Medicine, University of Michigan, Ann Arbor, Mich; Department of Human Genetics, University of Michigan, Ann Arbor, Mich.

Minhaj S Khaja (MS)

Division of Vascular and Interventional Radiology, Department of Radiology, University of Michigan, Ann Arbor, Mich.

David Williams (D)

Division of Vascular and Interventional Radiology, Department of Radiology, University of Michigan, Ann Arbor, Mich.

James C Stanley (JC)

Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, Mich.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH